Imbruvica (ibrutinib) - AbbVie, J&J
emavusertib (CA-4948) - Curis, Dr. Reddy’s
https://ash.confex.com/ash/2023/webprogram/Paper190391.html
 
Christian Grommes, MD1; Grzegorz S. Nowakowski, MD2; Allison C. Rosenthal, DO3; Matthew A. Lunning, DO, FACP4; Radhakrishnan Ramchandren, MD5; Lucia Regales, PhD6; Meaghan Fowle, BSc6; Maureen Lane, PhD6; Catherine Wang, MD6; Antonio Omuro, MD7; Lori A. Leslie, MD8; Carole Soussain, MD9; Anna Paulina Dabrowska-Iwanicka, MD10; Andrés José María Ferreri, MD11; Han Tun, MD12
 
Nov 3, 2023
 
Prev Next